These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 38575452

  • 1. Botulinum toxin-A as a treatment option for refractory idiopathic trigeminal neuralgia of the ophthalmic branch: a case report and literature review.
    Kandari A, Devaprasad BATP, Hernandez-Rivera P, Hernandez IA, Friesen R.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 May; 137(5):e73-e82. PubMed ID: 38575452
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin in trigeminal neuralgia.
    Castillo-Álvarez F, Hernando de la Bárcena I, Marzo-Sola ME.
    Med Clin (Barc); 2017 Jan 06; 148(1):28-32. PubMed ID: 27743594
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin and intractable trigeminal neuralgia.
    Türk U, Ilhan S, Alp R, Sur H.
    Clin Neuropharmacol; 2005 Jan 06; 28(4):161-2. PubMed ID: 16062093
    [Abstract] [Full Text] [Related]

  • 4. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.
    Bohluli B, Motamedi MH, Bagheri SC, Bayat M, Lassemi E, Navi F, Moharamnejad N.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan 06; 111(1):47-50. PubMed ID: 20674409
    [Abstract] [Full Text] [Related]

  • 5. [Trigeminal neuralgia: treatment options for refractory cases].
    Ruscheweyh R, Straube A.
    MMW Fortschr Med; 2019 May 06; 161(10):52-56. PubMed ID: 31129820
    [No Abstract] [Full Text] [Related]

  • 6. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
    Zúñiga C, Díaz S, Piedimonte F, Micheli F.
    Arq Neuropsiquiatr; 2008 Sep 06; 66(3A):500-3. PubMed ID: 18813708
    [Abstract] [Full Text] [Related]

  • 7. Botulinum Toxin Type A Injections as an Effective Treatment of Refractory Multiple Sclerosis-Related Trigeminal Pain - A Case Report.
    Calejo M, Salgado P, Moreira B, Correia C, Barros J.
    Headache; 2019 Sep 06; 59(8):1379-1381. PubMed ID: 31424566
    [No Abstract] [Full Text] [Related]

  • 8. Trigeminal Neuralgia With Extraoral Trigger Zone Successfully Treated With Intraoral Injections of Botulinum Toxin: A Case Report.
    Dinan JE, Smith A, Hawkins JM.
    Clin Neuropharmacol; 2020 Sep 06; 43(5):162-163. PubMed ID: 32947428
    [Abstract] [Full Text] [Related]

  • 9. Combining Botulinum Toxin (A) Injection With Peripheral Nerve Stimulation in a Patient for Intractable Ophthalmic Postherpetic Neuralgia.
    Li D, Xiao L.
    Neuromodulation; 2015 Dec 06; 18(8):769-71. PubMed ID: 26033071
    [Abstract] [Full Text] [Related]

  • 10. A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A.
    Guardiani E, Sadoughi B, Blitzer A, Sirois D.
    Laryngoscope; 2014 Feb 06; 124(2):413-7. PubMed ID: 23818108
    [Abstract] [Full Text] [Related]

  • 11. Intraoral administration of botulinum toxin for trigeminal neuropathic pain.
    Herrero Babiloni A, Kapos FP, Nixdorf DR.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jun 06; 121(6):e148-53. PubMed ID: 27181448
    [Abstract] [Full Text] [Related]

  • 12. Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial.
    Burmeister J, Holle D, Bock E, Ose C, Diener HC, Obermann M.
    Trials; 2015 Dec 03; 16():550. PubMed ID: 26634453
    [Abstract] [Full Text] [Related]

  • 13. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K.
    Toxins (Basel); 2021 Aug 29; 13(9):. PubMed ID: 34564609
    [Abstract] [Full Text] [Related]

  • 14. Acute treatment of trigeminal neuralgia with onabotulinum toxin A.
    Zúñiga C, Piedimonte F, Díaz S, Micheli F.
    Clin Neuropharmacol; 2013 Aug 29; 36(5):146-50. PubMed ID: 24045604
    [Abstract] [Full Text] [Related]

  • 15. Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?
    Shehata HS, El-Tamawy MS, Shalaby NM, Ramzy G.
    J Headache Pain; 2013 Nov 19; 14(1):92. PubMed ID: 24251833
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses.
    Shackleton T, Ram S, Black M, Ryder J, Clark GT, Enciso R.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jul 19; 122(1):61-71. PubMed ID: 27260275
    [Abstract] [Full Text] [Related]

  • 17. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials.
    Wei J, Zhu X, Yang G, Shen J, Xie P, Zuo X, Xia L, Han Q, Zhao Y.
    Brain Behav; 2019 Oct 19; 9(10):e01409. PubMed ID: 31541518
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Botulinum Toxin as Monotherapy in Symptomatic Trigeminal Neuralgia.
    Lunde HM, Torkildsen Ø, Bø L, Bertelsen AK.
    Headache; 2016 Jun 19; 56(6):1035-9. PubMed ID: 26992044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.